Literature DB >> 34227220

Association between prediabetes and adverse outcomes in heart failure.

Linlin Mai1, Weixing Wen1, Min Qiu1, Xiong Liu1, Lichang Sun1, Haoxiao Zheng1, Xiaoyan Cai2, Yuli Huang1,3,4.   

Abstract

AIMS: Heart failure (HF) patients with diabetes experienced significantly worse outcomes than those without diabetes. However, data on the prognostic impact of prediabetes in HF are inconclusive. This meta-analysis aimed to explore the association between prediabetes and the risk of all-cause mortality and adverse cardiac outcomes in HF patients.
MATERIALS AND METHODS: We searched multiple electronic databases (PubMed, Embase, and Google Scholar) for relevant studies up to March 31, 2021. Studies were included for analysis if multivariable adjusted relative risks of adverse outcomes were reported in prediabetic HF patients compared with those with normoglycaemia. Random-effects models were used to calculate the pooled hazard ratios (HRs) and 95% confidence intervals (CIs).
RESULTS: Twelve studies comprising 28 643 HF patients reported the risk of all-cause mortality and cardiac outcomes associated with prediabetes were included. The prevalence of prediabetes ranged from 9.6% to 37.2%. After a median follow-up duration of 2.3 years, HF patients with prediabetes were associated with an increased risk of all-cause mortality (HR 1.29, 95% CI 1.06-1.58), cardiovascular mortality (HR 1.59, 95% CI 1.09-2.32), HF hospitalization (HR 1.33, 95% CI 1.09-1.61), all-cause mortality and/or HF hospitalization (HR 1.22, 95% CI 1.01-1.47), as well as cardiovascular mortality and/or HF hospitalization (HR 1.21, 95% CI 1.07-1.37), respectively.
CONCLUSIONS: Prediabetes is associated with a worse prognosis in patients with HF. Further risk stratification and effective treatment strategies are needed in prediabetic HF patients to improve the prognosis. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  Prediabetes; adverse outcome; heart failure; mortality; prognosis

Year:  2021        PMID: 34227220     DOI: 10.1111/dom.14490

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  29 in total

Review 1.  The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling.

Authors:  Yiwei Gao; Wu Liu; Xin Su; Xinyi Li; Fangning Yu; Ning Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-05-24       Impact factor: 7.310

2.  Association Between Prognostic Nutritional Index and Prognosis in Patients With Heart Failure: A Meta-Analysis.

Authors:  Mei-Yu Chen; Jiang-Xiong Wen; Mei-Ting Lu; Xiang-Yu Jian; Xiao-Liang Wan; Zhi-Wen Xu; Jian-Qiu Liang; Jian-Di Wu
Journal:  Front Cardiovasc Med       Date:  2022-06-10

3.  Predictive Value of Non-high-Density Lipoprotein Cholesterol and Neutrophil-Lymphocyte Ratio for Coronary Artery Vulnerable Plaques in Type 2 Diabetes Mellitus.

Authors:  Xiyi Huang; Shaomin Yang; Qiang Zhao; Xinjie Chen; Jialing Pan; Shaofen Lai; Fusheng Ouyang; Lingda Deng; Yongxing Du; Xiaohong Li; Qiugen Hu; Baoliang Guo; Jiemei Liu
Journal:  Front Cardiovasc Med       Date:  2022-06-20

4.  Triglyceride-Glucose Index and Homeostasis Model Assessment-Insulin Resistance in Young Adulthood and Risk of Incident Congestive Heart Failure in Midlife: The Coronary Artery Risk Development in Young Adults Study.

Authors:  Xianghui Zeng; Dunzheng Han; Haobin Zhou; Yuting Xue; Xiao Wang; Qiong Zhan; Yujia Bai; Xingfu Huang; Qingchun Zeng; Hao Zhang; Zhuang Ma; Hao Ren; Dingli Xu
Journal:  Front Cardiovasc Med       Date:  2022-06-30

Review 5.  Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases.

Authors:  Poojarani Panda; Henu Kumar Verma; Saikrishna Lakkakula; Neha Merchant; Fairrul Kadir; Shamsur Rahman; Mohammad Saffree Jeffree; Bhaskar V K S Lakkakula; Pasupuleti Visweswara Rao
Journal:  Oxid Med Cell Longev       Date:  2022-06-24       Impact factor: 7.310

6.  Prediabetes Burden in Nigeria: A Systematic Review and Meta-Analysis.

Authors:  Musa Ado Bashir; Anas Ibrahim Yahaya; Mukhtar Muhammad; Ashiru Hassan Yusuf; Isyaku Gwarzo Mukhtar
Journal:  Front Public Health       Date:  2021-12-23

7.  The Nonlinear Relationship Between Total Bilirubin and Coronary Heart Disease: A Dose-Response Meta-Analysis.

Authors:  Chaoxiu Li; Wenying Wu; Yumeng Song; Shuang Xu; Xiaomei Wu
Journal:  Front Cardiovasc Med       Date:  2022-01-05

8.  Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Authors:  Jin-Wen Luo; Wen-Hui Duan; Yan-Qiao Yu; Lei Song; Da-Zhuo Shi
Journal:  Front Cardiovasc Med       Date:  2021-12-02

9.  Notoginsenoside R1 Protects Against High Glucose-Induced Cell Injury Through AMPK/Nrf2 and Downstream HO-1 Signaling.

Authors:  Fawang Du; Huiling Huang; Yalin Cao; Yan Ran; Qiang Wu; Baolin Chen
Journal:  Front Cell Dev Biol       Date:  2021-12-01

10.  α-Linolenic Acid and Risk of Heart Failure: A Meta-Analysis.

Authors:  Jiandi Wu; Min Qiu; Lichang Sun; Jiangxiong Wen; Dong-Liang Liang; Sulin Zheng; Yuli Huang
Journal:  Front Cardiovasc Med       Date:  2022-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.